Clinical Trial Update: Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating single-fraction HDR brachytherapy combined with hypofractionated external beam radiotherapy for low-risk prostate cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AC Camargo Cancer Center | Conditions: Prostatic Neoplasms | Phase 2 | Status: UNKNOWN